Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Synergy Pharmaceuticals Inc (NASDAQ:SGYP)

3.74
Delayed Data
As of Jun 29
 +0.11 / +3.03%
Today’s Change
2.50
Today|||52-Week Range
10.15
-34.04%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$652.6M

Company Description

Synergy Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development and commercialization of novel gastrointestinal (GI) therapies. Its product includes plecanatide and dolcanatide. The company was founded by Kunwar Shailubhai on November 15, 2005 and is headquartered in New York, NY.

Contact Information

Synergy Pharmaceuticals, Inc.
420 Lexington Avenue
New York New York 10170
P:(212) 297-0020
Investor Relations:
(212) 584-7610

Employees

Shareholders

Other institutional30.64%
Individual stakeholders16.34%
Mutual fund holders14.83%

Top Executives

Gary S. JacobChairman, President & Chief Executive Officer
Laura BarrowSenior Vice President-Clinical Operations
Bernard F. DenoyerSecretary & Senior Vice President-Finance
Kunwar ShailubhaiChief Scientific Officer & Executive VP
Patrick H. GriffinChief Medical Officer & Executive Vice President